Join to View Full Profile
66 Elm StBuffalo, NY 14203
Phone+1 716-845-8075
Fax+1 716-845-7748
Dr. Maslak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
University of MichiganResidency, Internal Medicine, 1984 - 1987
Icahn School of Medicine at Mount SinaiClass of 1984
Certifications & Licensure
NY State Medical License 1987 - 2026
NJ State Medical License 2018 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Clinical Trials
- High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission Start of enrollment: 1994 Mar 01
- Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome Start of enrollment: 1996 Jul 01
- Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer Start of enrollment: 2000 May 01
Publications & Presentations
PubMed
- Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.Theresa Hahn, Megan M Herr, Paul K Wallace, Yali Zhang, Shernan Holtan
Leukemia & Lymphoma. 2026-02-01 - Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients ...Megan M Herr, Sophia R Balderman, Paul K Wallace, Yali Zhang, Joseph D Tario Jr
Transplantation and Cellular Therapy. 2024-08-01 - 1 citationsImmune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.Giovanna Melica, Elaina Preston, Meighan Palazzo, Kenneth Seier, Florent Malard
Bone Marrow Transplantation. 2024-05-01
Press Mentions
Pioneering Hematology/Oncology Expert Joins Roswell Park in Vice Chair RoleMarch 20th, 2023- Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy ProgramDecember 7th, 2023
- Inside Roswell Park's Big Bet on Cell Therapy and What That Means for Cancer CareApril 4th, 2024
Professional Memberships
- Fellow
- Member
- Member
- International Society for Advancement of CytometryMember
- International Society for Cell & Gene TherapyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
